Àngels Arcusa - Concepedia

Author

Àngels Arcusa

Consorci Sanitari de Terrassa

Also Known As

A Arcusa, A. Arcusa, Angels Arcusa, Arcusa, A., Lluch, Ana, À. Arcusa, Àngels Arcusa, Ángels Arcusa

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Consorci Sanitari de Terrassa Corporació Sanitària Parc Taulí Hospital Del Mar Hospital Clínico San Carlos Institut Català d'Oncologia

ÀA

About

Àngels Arcusa is an author at Consorci Sanitari de Terrassa specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	459
2	Health Sciences	1	1	25
3	Natural Sciences	1	1	13
4	Public Health	1	1	64
5	Social Sciences	1	1	32

Àngels Arcusa

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled Trial Francisco Rodríguez‐Moranta, Joan Saló, Àngels Arcusa, Journal of Clinical Oncology	2005	297
Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer Miguel Martín, Miguel Ángel Seguí, Antonio Antón, New England Journal of Medicine	2010	208
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen Miguel Martín, Aňa Lluch, Miguel Ángel Seguí, Annals of Oncology Breast OncologyBreast Cancer PatientsMedicineHealth-related QualityTac Regimen	2006	204
Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer Luis Cirera, A. Balil, E. Batiste-Alentorn, Journal of Clinical Oncology	1999	115
Predicting response and survival in chemotherapy-treated triple-negative breast cancer Aleix Prat, Aňa Lluch, Joan Albanell, British Journal of Cancer	2014	110
Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing Emma Borràs, Ismael Jurado, Imma Hernán, BMC Cancer	2011	89
Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study Cesar Pico, Miguel Martín, Carlos Jara, Annals of Oncology	2003	84
Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain Rebeca Font, Josep Alfons Espinàs, Miguel Gil‐Gil, British Journal of Cancer	2012	73
Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors Noémie Travier, Ana Fonseca‐Nunes, Casimiro Javierre, Medical Oncology ObesityNutritionPhysical ActivityLifestyle ModificationNutritional Patterns	2013	64
A PAM50-Based Chemoendocrine Score for Hormone Receptor–Positive Breast Cancer with an Intermediate Risk of Relapse Aleix Prat, Aňa Lluch, Arran Turnbull, Clinical Cancer Research	2016	44

Page 1